Trivium Point Advisory’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.05M | Buy |
12,027
+2,217
| +23% | +$517K | 0.28% | 91 |
|
|
2026
Q1 | $2.4M | Sell |
9,810
-2,173
| -18% | -$506K | 0.43% | 59 |
|
|
2025
Q4 | $2.48M | Buy |
11,983
+429
| +4% | +$84.8K | 0.25% | 100 |
|
|
2025
Q3 | $2.14M | Buy |
11,554
+323
| +3% | +$55.3K | 0.22% | 113 |
|
|
2025
Q2 | $1.72M | Buy |
11,231
+1,131
| +11% | +$174K | 0.19% | 132 |
|
|
2025
Q1 | $1.67M | Buy |
10,100
+722
| +8% | +$113K | 0.21% | 121 |
|
|
2024
Q4 | $1.36M | Buy |
9,378
+1,878
| +25% | +$291K | 0.17% | 143 |
|
|
2024
Q3 | $1.15M | Sell |
7,500
-4
| -0.1% | -$637 | 0.16% | 151 |
|
|
2024
Q2 | $1.1M | Buy |
7,504
+640
| +9% | +$95.2K | 0.16% | 145 |
|
|
2024
Q1 | $1.09M | Buy |
6,864
+262
| +4% | +$41.7K | 0.23% | 106 |
|
|
2023
Q4 | $1.03M | Sell |
6,602
-100
| -1% | -$15.3K | 0.25% | 106 |
|
|
2023
Q3 | $1.04M | Sell |
6,702
-15
| -0.2% | -$2.48K | 0.29% | 106 |
|
|
2023
Q2 | $1.11M | Sell |
6,717
-70
| -1% | -$11.3K | 0.3% | 108 |
|
|
2023
Q1 | $1.05M | Sell |
6,787
-265
| -4% | -$42.8K | 0.28% | 114 |
|
|
2022
Q4 | $1.27M | Hold |
7,052
| – | – | 0.37% | 97 |
|
|
2022
Q3 | $1.14M | Sell |
7,052
-179
| -2% | -$30.3K | 0.35% | 94 |
|
|
2022
Q2 | $1.29M | Sell |
7,231
-819
| -10% | -$146K | 0.39% | 88 |
|
|
2022
Q1 | $1.47M | Buy |
8,050
+391
| +5% | +$66.5K | 0.33% | 101 |
|
|
2021
Q4 | $1.31M | Buy |
7,659
+6,280
| +455% | +$1.03M | 0.27% | 107 |
|
|
2021
Q3 | $222K | Sell |
1,379
-15,413
| -92% | -$2.63M | 0.05% | 208 |
|
|
2021
Q2 | $2.77M | Buy |
16,792
+485
| +3% | +$80.3K | 0.69% | 48 |
|
|
2021
Q1 | $2.68M | Buy |
16,307
+324
| +2% | +$52.4K | 0.72% | 35 |
|
|
2020
Q4 | $2.56M | Sell |
15,983
-339
| -2% | -$50K | 0.74% | 31 |
|
|
2020
Q3 | $2.43M | Buy |
16,322
+224
| +1% | +$33.1K | 0.86% | 32 |
|
|
2020
Q2 | $2.3M | Buy |
16,098
+308
| +2% | +$44.9K | 0.91% | 29 |
|
|
2020
Q1 | $2.26M | Sell |
15,790
-2,287
| -13% | -$324K | 1.16% | 16 |
|
|
2019
Q4 | $2.64M | Buy |
18,077
+482
| +3% | +$65.4K | 1.03% | 18 |
|
|
2019
Q3 | $2.27M | Buy |
17,595
+932
| +6% | +$123K | 1.04% | 21 |
|
|
2019
Q2 | $2.32M | Buy |
16,663
+1,509
| +10% | +$209K | 1.03% | 20 |
|
|
2019
Q1 | $2.12M | Buy |
15,154
+709
| +5% | +$95K | 0.99% | 24 |
|
|
2018
Q4 | $1.86M | Buy |
+14,445
| New | +$2.01M | 1.13% | 25 |
|
Other funds holding JNJ
Trivium Point Advisory's JNJ Position: Q2 2026 in Review
Trivium Point Advisory increased its Johnson & Johnson (JNJ) stake by 23% in Q2 2026, buying an estimated $517K and bringing the position to 12,027 shares worth $3.05M. The position accounts for 0.28% of the portfolio, ranked #91.
Trivium Point Advisory first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Trivium Point Advisory held 12,027 shares of Johnson & Johnson worth $3.05M as of Q2 2026.
- Trivium Point Advisory bought 2,217 Johnson & Johnson shares in Q2 2026, an estimated $517K.
- Johnson & Johnson made up 0.28% of Trivium Point Advisory's portfolio in Q2 2026, its #91 holding.
- Trivium Point Advisory first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.